These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10048092)

  • 21. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
    Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
    Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
    Jang KS; Han HX; Paik SS; Brown PH; Kong G
    Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases.
    Martinez LM; Labovsky V; Calcagno Mde L; Davies KM; Rivello HG; Wernicke A; Calvo JC; Chasseing NA
    Pathol Res Pract; 2016 Apr; 212(4):350-5. PubMed ID: 26872535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
    Hansen S; Sørensen FB; Vach W; Grabau DA; Bak M; Rose C
    Histopathology; 2004 May; 44(5):428-36. PubMed ID: 15139990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying tumour vascularity in non-luminal breast cancers.
    Kraby MR; Opdahl S; Akslen LA; Bofin AM
    J Clin Pathol; 2017 Sep; 70(9):766-774. PubMed ID: 28249942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidine phoshorylase expression in breast cancer: the prognostic significance and its association with other angiogenesis related proteins and extracellular matrix components.
    Ioachim E
    Histol Histopathol; 2008 Feb; 23(2):187-96. PubMed ID: 17999375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.
    Nishimiya H; Kosaka Y; Yamashita K; Minatani N; Kikuchi M; Ema A; Nakamura K; Waraya M; Sengoku N; Tanino H; Kuranami M; Watanabe M
    Anticancer Res; 2014 Jan; 34(1):259-68. PubMed ID: 24403472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.
    Keyhani E; Muhammadnejad A; Behjati F; Sirati F; Khodadadi F; Karimlou M; Moghaddam FA; Pazhoomand R
    Asian Pac J Cancer Prev; 2013; 14(12):7651-6. PubMed ID: 24460348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
    McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
    Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of tumor cells in bone marrow in breast cancer].
    Untch M; Nestle-Krämling C; Konecny G; Harbeck N; Funke I; Kimmig R; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():308-10. PubMed ID: 8118327
    [No Abstract]   [Full Text] [Related]  

  • 33. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
    Nakopoulou L; Lekkas N; Lazaris AC; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
    Anticancer Res; 1999; 19(5C):4547-53. PubMed ID: 10650809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermography. Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast.
    Sterns EE; Zee B; SenGupta S; Saunders FW
    Cancer; 1996 Apr; 77(7):1324-8. PubMed ID: 8608510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior.
    Lee JS; Kim HS; Jung JJ; Kim YB; Park CS; Lee MC
    Anal Quant Cytol Histol; 2001 Apr; 23(2):161-8. PubMed ID: 11332083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.
    Lipponen P; Ji H; Aaltomaa S; Syrjänen K
    J Cancer Res Clin Oncol; 1994; 120(11):645-50. PubMed ID: 7962040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
    Raica M; Cimpean AM; Ceausu R; Ribatti D
    Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological behavior of human breast cancer micrometastases.
    Klauber-DeMore N; Van Zee KJ; Linkov I; Borgen PI; Gerald WL
    Clin Cancer Res; 2001 Aug; 7(8):2434-9. PubMed ID: 11489823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.